Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 12, 2015
Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of CancerMunjal Pandya, Kellee Britt, Brad Hoffman, et al.
Journal of Genetic Syndromes & Gene Therapy|December 25, 2012
Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of HemophiliaLi Zhong, Giridhara R Jayandharan, George V Aslanidi, et al.
Frontiers in Microbiology|September 29, 2011
Innate Immune Responses to AAV VectorsGeoffrey L Rogers, Ashley T Martino, George V Aslanidi, et al.
The Journal of General Virology|August 23, 2015
Productive life cycle of adeno-associated virus serotype 2 in the complete absence of a conventional polyadenylation signalLina Wang, Zifei Yin, Yuan Wang, et al.
Vaccine|April 14, 2012
High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectorsGeorge V Aslanidi, Angela E Rivers, Luis Ortiz, et al.
Journal of Visualized Experiments : Jove|March 30, 2011
High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectorsChen Ling, Yuan Lu, Binbin Cheng, et al.
Plos One|March 26, 2013
Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?George V Aslanidi, Angela E Rivers, Luis Ortiz, et al.
Pageof 2